Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Statement on the use of AI
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Ahead of print
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Read
Archive
Toc Alert
Current issue
Ahead of print
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Read
Archive
Toc Alert
Current issue
Ahead of print
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Letters to the editor
2022
>
Volume 80 - Number 4
Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
2022
>
Volume 80 - Number 4
Nitrosamines in antihypertеnsives, metformin and ranitidine as cofactors for melanoma and development of other cancers. Expert group opinion
2025
>
Volume 83 - Number 4
Glucagon-like peptide-1 receptor agonists in dermatology: more than meets the eye
2023
>
Volume 81 - Number 3
Corticosteroids use in infantile hemangiomas: revisiting an old therapy
2025
>
Volume 83 - Number 4
Comment on: Basal cell carcinoma in a nevus sebaceous of the scalp
2023
>
Volume 81 - Number 3
The potential use of artificial intelligence in the evaluation and treatment of patients with psoriasis